Tennessee Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Healthcare Today.

Press releases published on September 14, 2026

9 minutes ago

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

Indeterminate GlobeNewswire

9 minutes ago

Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire

9 minutes ago

Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia

Indeterminate GlobeNewswire

9 minutes ago

Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)

Indeterminate GlobeNewswire

9 minutes ago

Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market

Indeterminate GlobeNewswire

9 minutes ago

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

9 minutes ago

Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development

Indeterminate GlobeNewswire

9 minutes ago

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

Indeterminate GlobeNewswire

9 minutes ago

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

Indeterminate GlobeNewswire

9 minutes ago

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

9 minutes ago

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Indeterminate GlobeNewswire

9 minutes ago

Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors

Indeterminate GlobeNewswire

9 minutes ago

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Indeterminate GlobeNewswire

9 minutes ago

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Indeterminate GlobeNewswire

9 minutes ago

Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)

Indeterminate GlobeNewswire

9 minutes ago

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

39 minutes ago

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Indeterminate GlobeNewswire

an hour ago

Sol y Vida Launches Nationwide Bilingual Telehealth Platform Built for Latino Communities

Indeterminate GlobeNewswire

an hour ago

Etienna Bio Completes FDA INTERACT Meeting for ETB-001

Indeterminate GlobeNewswire

an hour ago

WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC

Indeterminate GlobeNewswire